NEW YORK--(BUSINESS WIRE)--Wall Street Media is presenting an exclusive highlight video from the presentation of Dr. Clay Siegall, CEO of Seattle Genetics (NASDAQGM: SGEN) from the Invest Northwest(TM) Investor and CEO Forum on Tuesday, March 18, 2008 at the Bell Harbor International Conference Center in Seattle, WA. Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.
